Increased Platelet Activation demonstrated by Elevated CD36 and P-Selectin Expression in 1-Year Post-Recovered COVID-19 Patients.
- Resource Type
- Article
- Authors
- Wang, Samuel Sherng Young; Chee, Keefe; Wong, Shiun Woei; Tan, Guat Bee; Ang, Hong; Leung, Bernard PuiLam; Tan, Chuen Wen; Ramanathan, Kollengode; Dalan, Rinkoo; Cheung, Christine; Lye, David Chien; Young, Barnaby Edward; Yap, Eng Soo; Chia, Yew Woon; Fan, Bingwen Eugene
- Source
- Seminars in Thrombosis & Hemostasis. Jul2023, Vol. 49 Issue 5, p561-564. 4p.
- Subject
- *BLOOD platelet activation
*GENE expression
*SARS-CoV-2
*COVID-19
*BLOOD platelet disorders
- Language
- ISSN
- 0094-6176
Coronavirus disease 2019 (COVID-19)-associated hypercoagulability and platelet hyperactivity are characteristic of COVID-19 infection and contribute to an increased thrombotic burden. [14] Post-COVID-19 persistent platelet activation may explain why high-risk patients such as intensive care unit patients could benefit from antiplatelet treatment regimens post-COVID-19 infection. [Extracted from the article]